357 related articles for article (PubMed ID: 22179034)
1. The European CRT Survey: 1 year (9-15 months) follow-up results.
Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
[TBL] [Abstract][Full Text] [Related]
2. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
[TBL] [Abstract][Full Text] [Related]
3. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
[TBL] [Abstract][Full Text] [Related]
5. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
Freeman JV; Masoudi FA
Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
[TBL] [Abstract][Full Text] [Related]
8. Long term effects of cardiac resynchronization therapy in non-ambulatory NYHA IV heart failure patients.
Theodorakis G; Katsikis A; Livanis E; Kostopoulou A; Adamopoulos S; Tsiapras D; Voudris V
Pacing Clin Electrophysiol; 2011 Nov; 34(11):1553-60. PubMed ID: 21913946
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
[TBL] [Abstract][Full Text] [Related]
10. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
11. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
12. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.
Versteeg H; van den Broek KC; Theuns DA; Mommersteeg PM; Alings M; van der Voort PH; Jordaens L; Pedersen SS
Am J Cardiol; 2011 Oct; 108(8):1155-9. PubMed ID: 21821227
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
[TBL] [Abstract][Full Text] [Related]
14. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
[TBL] [Abstract][Full Text] [Related]
15. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
[TBL] [Abstract][Full Text] [Related]
16. Approach to cardiac resyncronization therapy.
Dobreanu D; Dagres N; Svendsen JH; Marinskis G; Bongiorni MG; Blomström-Lundqvist C
Europace; 2012 Sep; 14(9):1359-62. PubMed ID: 22930718
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
Pires LA; Abraham WT; Young JB; Johnson KM;
Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
[TBL] [Abstract][Full Text] [Related]
18. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
Zaręba W
Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
